The FDA has stated that complications linked to transvaginal mesh implants are 'not rare' and warned that use of such devices may actually be more harmful.
New York, New York (PRWEB) June 13, 2013
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, reports that, according to a June 10th Pretrial Order issued to American Medical Systems Inc. by the U.S. District Court for the Southern District of West Virginia, presentations regarding the selection of Bellwether Cases are to be made on June 25, 2013, with the court selecting five transvaginal mesh bellwether trials. Expert Discovery for the Bellwether Cases is to be completed by Sept. 25, 2013 (In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2325).
“On a daily basis, our nurses speak with women who suffer from the serious side effects and complications allegedly caused by their transvaginal mesh implant,” says Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “We look forward to telling their stories so women can make better-informed decisions about whether to use this medical device as treatment for their Pelvic Organ Prolapse (POP) and/or Stress Urinary Incontinence (SUI).”
Thousands of transvaginal mesh lawsuits have been formulated into five MDLs pending in U.S. District Court for the Southern District of West Virginia. The titles of the other four are: In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation, MDL No. 2326; In Re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2187; In Re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2327; and In Re: Coloplast Corp., Pelvic Support Systems Products Liability Litigation, MDL No. 2387.
The U.S. Food and Drug Administration (FDA) reports that the most common complications associated with transvaginal mesh may include:
- Mesh erosion through the vagina (also called exposure, extrusion, or protrusion)
- Pain during sexual intercourse (dyspareunia)
- Organ perforation
- Urinary problems
The FDA has stated that complications linked to transvaginal mesh implants are “not rare” and warned that use of such devices may actually be more harmful compared to alternative methods for treating pelvic organ prolapse. The FDA has also asked 33 manufacturers, including Johnson & Johnson, to conduct post-market safety studies in order to investigate the effect of vaginal mesh on organ damage and other health concerns.
Recently, the first transvaginal mesh lawsuit to go to trial led to an $11.1 million verdict in favor of the Plaintiff (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey), according to a Feb. 28, 2013, Bloomberg report, which added that Gross’s lawsuit was the first of 4,000 Gynecare Prolift cases expected to go to trial. Johnson & Johnson was ordered to pay $3.35 million in compensatory damages and $7.76 million for punitive damages.
Parker Waichman LLP continues to offer free lawsuit consultations to victims of transvaginal mesh injuries. If you or a loved one experienced complications following POP and SUI surgery with mesh, please visit the firm's transvaginal mesh injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
Contact: Parker Waichman LLP
Gary Falkowitz, Managing Attorney